Article info
PDFEditorial
Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer
- Correspondence to Professor Pier Luigi Meroni, Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano–Istituto di Ricovero e Cura a Carattere Scientifico, 20145 Milano, Italy; pierluigi.meroni{at}unimi.it
Citation
Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer
Publication history
- Received June 21, 2021
- Accepted July 15, 2021
- First published August 2, 2021.
Online issue publication
August 12, 2021
Article Versions
- Previous version (2 August 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage